LUMINITY

This brand name is authorized in Austria, Estonia, Spain, Ireland, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug LUMINITY contains one active pharmaceutical ingredient (API):

1 Perflutren
UNII CK0N3WH0SR - PERFLUTREN

When used in conjunction with diagnostic ultrasound, perflutren provides opacification of cardiac chambers, improvement in delineation of endocardial borders, enhancement of the Doppler signal, and visualisation of wall motion and blood flow within the heart.

Read about Perflutren

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
LUMINITY Gas and solvent for dispersion for injection/infusion European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V08DA04 V Various → V08 Contrast media → V08D Ultrasound contrast media → V08DA Ultrasound contrast media
Discover more medicines within V08DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1266869, 1537905
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 06361001
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 135637
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1029638, 1029639
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100311659
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W54777001, W54777002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.